查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547555

全球精准医疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Precision Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

全球精准医疗市场需求预计将从2023年的842.1亿美元达到近1,698.8亿美元的市场规模，2024-2032年研究期间复合年增长率为8.11%。

精准医疗，也称为个人化医疗，是近年来快速成长的医疗保健领域的未来趋势。精准医学基于一个独特的概念，即感染相同疾病的两个人不需要对该疾病有相同的身体反应。但取决于周围环境以及患者基因和症状的影响。此外，它还取决于患者对特定疾病的反应能力，使医生和研究人员能够组织必要的治疗。精准医学主要包括系统生物学和全景组学，从分子层面检查个别患者患病的原因。其次是使用浓缩药物来解决个别患者的疾病。精准医疗提供了许多好处，例如根据患者需求和疾病类别量身定制的高效治疗。此外，精准医疗可以降低治疗成本，并有助于减少重复用药。

市场动态

该市场的主要驱动因素包括药物及其伴随诊断检测的批准增加、DNA 的成本效益分析、癌症发病率的增加以及数据驱动的医疗保健的兴起。此外，「多组学」在研究中的日益普及，以及高通量定序平台的渗透，也正在催生精准医疗场景。针对特定应用的管道中的标靶分子数量呈指数级增长，特别是在肿瘤学领域，在预测期内创造了新的机会。当前药物发现价格的不断上涨和监管要求的不断提高增加了对个人化产品的需求。伴随诊断的发展似乎提供了一套工具以及相关的临床和生物学资讯来满足不同製药公司的需求。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球精准医疗市场的各个细分市场进行了包容性评估。精准医疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

精准医疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按申请

  • 诊断（基因测试、基于生物标记的测试、深奥测试、其他测试）
  • 治疗药物（抑制剂药物、单株抗体、细胞和基因治疗、抗病毒和抗逆转录病毒药物、其他治疗药物）

按指示

  • 肿瘤学
  • 中枢神经系统疾病
  • 免疫学
  • 呼吸系统疾病
  • 遗传性疾病
  • 皮肤病
  • 其他适应症

依技术

  • 基因组学
  • 生物资讯学
  • 大数据分析
  • 生物标记检测
  • 高通量筛选
  • 其他技术

按最终用户

  • 医院
  • 诊断实验室
  • 其他最终用户

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲精准医疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。精准医疗市场的主要参与者包括 Abbott Laboratories Inc.、Abbie Inc.、AstraZeneca Plc、BioMerieux SA、Bristol-Myers Squibb Company、Cepheid（Danaher Corporation）、EliLilly & Company、F. Hoffmann-La Roche、GlaxoSmithKline Plc、LaboraKline Plc Corporation Of America Holdings (Covance Inc.)、Myriad Genetics Inc.、Novartis AG、Pfizer Inc.、QIAGEN NV.、Quest Diagnostics、Takeda Pharmaceutical Company Limited、ThermFisher Scientific Inc.、Vyant Bio Inc. (Cancer Genetics Inc.) 。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：精准医疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按指标进行的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球精准医疗市场分析：依应用分类

  • 概述：按应用
  • 历史与预测资料分析：按应用分类
  • 诊断（基因测试、基于生物标记的测试、深奥测试、其他测试）
  • 治疗药物（抑制剂药物、单株抗体、细胞和基因治疗、抗病毒和抗逆转录病毒药物、其他治疗药物）

第 6 章：全球精准医疗市场分析：依适应症分类

  • 按指示概述
  • 按指示进行历史和预测资料分析
  • 肿瘤学
  • 中枢神经系统疾病
  • 免疫学
  • 呼吸系统疾病
  • 遗传性疾病
  • 皮肤病
  • 其他适应症

第 7 章：全球精准医疗市场分析：依技术分类

  • 依技术概述
  • 透过技术进行历史和预测数据分析
  • 基因组学
  • 生物资讯学
  • 大数据分析
  • 生物标记检测
  • 高通量筛选
  • 其他技术

第 8 章：全球精准医疗市场分析：依最终使用者分类

  • 最终用户概述
  • 最终用户的历史和预测数据分析
  • 医院
  • 诊断实验室
  • 其他最终用户

第 9 章：全球精准医疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：精准医疗公司的竞争格局

  • 精准医疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Abbott Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abbie Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AstraZeneca Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioMerieux SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bristol-Myers Squibb Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cepheid (Danaher Corporation)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • EliLilly & Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Laboratory Corporation Of America Holdings (Covance Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Myriad Genetics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN NV.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takeda Pharmaceutical Company Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ThermFisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Vyant Bio Inc. (Cancer Genetics Inc.)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11214898

The global demand for Precision Medicine Market is presumed to reach the market size of nearly USD 169.88 Billion by 2032 from USD 84.21 Billion in 2023 with a CAGR of 8.11% under the study period 2024-2032.

The precision medicine, also known as personalized medicines, is the upcoming trend in the healthcare sector that grows rapidly over the years. Precision medicine is based on a unique concept that defines, two people infected with the same disease don't need to have the same physical response toward the disorder. However, it depends on the surrounding environment and the influence of genes and symptoms of the patient. Moreover, it also depends on patients' ability to respond to that particular disease, enabling the doctors and researchers to organize the necessary treatment. Precision medicine mainly includes system biology and panomics to examine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's ailments. Precision medicine offers many benefits, such as efficient treatment customized to patients' needs and disease categories. Moreover, precision medicine can reduce the cost of treatment and help decrease repeated administration of medications.

MARKET DYNAMICS

The market is mainly driven by increasing approval of the drug and its companion diagnostic assay, cost-effective profiling of DNA, increasing incidence of cancer, and the rise of data-driven healthcare. In addition, the rising use of "multi-omics" in research, along with the penetration of high-throughput sequencing platforms, is also surging up the precision medicine scenario. The number of targeted molecules in the pipeline for a specific application has been exponentially growing, specifically in oncology has created a new opportunity over the forecast period. The current escalating price of drug discovery and increasing regulatory requirements have increased the demand for an individualized product. The development of companion diagnostics appears to offer a set of tools and relevant clinical and biological information to address various pharmaceutical companies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Precision Medicine. The growth and trends of Precision Medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Precision Medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests)
  • Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics)

By Indication

  • Oncology
  • CNS Disorders
  • Immunology
  • Respiratory Diseases
  • Genetic Disorders
  • Skin Diseases
  • Other Indications

By Technology

  • Genomics
  • Bioinformatics
  • Big Data Analytics
  • Biomarker Detection
  • High Throughput Screening
  • Other Technologies

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Precision Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Precision Medicine market include Abbott Laboratories Inc., Abbie Inc., AstraZeneca Plc, BioMerieux SA, Bristol-Myers Squibb Company, Cepheid (Danaher Corporation), EliLilly & Company, F. Hoffmann-La Roche, GlaxoSmithKline Plc, Laboratory Corporation Of America Holdings (Covance Inc.), Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV., Quest Diagnostics, Takeda Pharmaceutical Company Limited, ThermFisher Scientific Inc., Vyant Bio Inc. (Cancer Genetics Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PRECISION MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Technology
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data Analysis By Application
  • 5.3. Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Historic and Forecast Sales By Regions
  • 5.4. Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY INDICATION

  • 6.1. Overview By Indication
  • 6.2. Historical and Forecast Data Analysis By Indication
  • 6.3. Oncology Historic and Forecast Sales By Regions
  • 6.4. CNS Disorders Historic and Forecast Sales By Regions
  • 6.5. Immunology Historic and Forecast Sales By Regions
  • 6.6. Respiratory Diseases Historic and Forecast Sales By Regions
  • 6.7. Genetic Disorders Historic and Forecast Sales By Regions
  • 6.8. Skin Diseases Historic and Forecast Sales By Regions
  • 6.9. Other Indications Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

  • 7.1. Overview By Technology
  • 7.2. Historical and Forecast Data Analysis By Technology
  • 7.3. Genomics Historic and Forecast Sales By Regions
  • 7.4. Bioinformatics Historic and Forecast Sales By Regions
  • 7.5. Big Data Analytics Historic and Forecast Sales By Regions
  • 7.6. Biomarker Detection Historic and Forecast Sales By Regions
  • 7.7. High Throughput Screening Historic and Forecast Sales By Regions
  • 7.8. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 8.5. Other End-Users Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

  • 10.1. Precision Medicine Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Abbott Laboratories Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Abbie Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. AstraZeneca Plc
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. BioMerieux SA
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Bristol-Myers Squibb Company
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Cepheid (Danaher Corporation)
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. EliLilly & Company
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. F. Hoffmann-La Roche
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. GlaxoSmithKline Plc
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Laboratory Corporation Of America Holdings (Covance Inc.)
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Myriad Genetics Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Novartis AG
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Pfizer Inc.
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. QIAGEN NV.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Quest Diagnostics
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Takeda Pharmaceutical Company Limited
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. ThermFisher Scientific Inc.
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments
  • 11.20. Vyant Bio Inc. (Cancer Genetics Inc.)
    • 11.20.1 Company Overview
    • 11.20.2 Company Revenue
    • 11.20.3 Products
    • 11.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Application (USD MN)
  • Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Market Sales By Geography (USD MN)
  • Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • CNS Disorders Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Respiratory Diseases Market Sales By Geography (USD MN)
  • Genetic Disorders Market Sales By Geography (USD MN)
  • Skin Diseases Market Sales By Geography (USD MN)
  • Other Indications Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Genomics Market Sales By Geography (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Biomarker Detection Market Sales By Geography (USD MN)
  • High Throughput Screening Market Sales By Geography (USD MN)
  • Other Technologies Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Precision Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Precision Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Precision Medicine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Application (USD MN)
  • Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Market Sales By Geography (USD MN)
  • Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • CNS Disorders Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Respiratory Diseases Market Sales By Geography (USD MN)
  • Genetic Disorders Market Sales By Geography (USD MN)
  • Skin Diseases Market Sales By Geography (USD MN)
  • Other Indications Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Genomics Market Sales By Geography (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Biomarker Detection Market Sales By Geography (USD MN)
  • High Throughput Screening Market Sales By Geography (USD MN)
  • Other Technologies Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.